Literature DB >> 33493106

Prevalence of SARS-CoV-2 Antibodies in First Responders and Public Safety Personnel, New York City, New York, USA, May-July 2020.

Samira Sami, Lara J Akinbami, Lyle R Petersen, Addie Crawley, Susan L Lukacs, Don Weiss, Rebecca A Henseler, Nga Vuong, Lisa Mackey, Anita Patel, Lisa A Grohskopf, Beth Maldin Morgenthau, Demetre Daskalakis, Preeti Pathela.   

Abstract

We conducted a serologic survey in public service agencies in New York City, New York, USA, during May-July 2020 to determine prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among first responders. Of 22,647 participants, 22.5% tested positive for SARS-CoV-2-specific antibodies. Seroprevalence for police and firefighters was similar to overall seroprevalence; seroprevalence was highest in correctional staff (39.2%) and emergency medical technicians (38.3%) and lowest in laboratory technicians (10.1%) and medicolegal death investigators (10.8%). Adjusted analyses demonstrated association between seropositivity and exposure to SARS-CoV-2-positive household members (adjusted odds ratio [aOR] 3.52 [95% CI 3.19-3.87]), non-Hispanic Black race or ethnicity (aOR 1.50 [95% CI 1.33-1.68]), and severe obesity (aOR 1.31 [95% CI 1.05-1.65]). Consistent glove use (aOR 1.19 [95% CI 1.06-1.33]) increased likelihood of seropositivity; use of other personal protective equipment had no association. Infection control measures, including vaccination, should be prioritized for frontline workers.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; New York; New York City; SARS-CoV-2; United States; coronavirus disease; emergency responders; personal protective equipment; public safety; respiratory infections; seroepidemiologic studies; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses

Year:  2021        PMID: 33493106     DOI: 10.3201/eid2703.204340

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  7 in total

1.  Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohort.

Authors:  Parham Sendi; Marc Thierstein; Nadja Widmer; Flora Babongo Bosombo; Annina Elisabeth Büchi; Dominik Güntensperger; Manuel Raphael Blum; Rossella Baldan; Caroline Tinguely; Brigitta Gahl; Dik Heg; Elitza S Theel; Elie Berbari; Andrea Endimiani; Peter Gowland; Christoph Niederhauser
Journal:  Immun Inflamm Dis       Date:  2022-07

2.  SARS-CoV-2 Viral Incidence, Antibody Point Prevalence, Associated Population Characteristics, and Vaccine Attitudes, South Carolina, February 2021.

Authors:  Melissa S Nolan; Virginie Daguise; Megan Davis; Joan M Duwve; Windsor Westbrook Sherrill; Moonseong Heo; Alain H Litwin; Mufaro Kanyangarara; Stella Self; Rongjie Huang; Jan M Eberth; Lídia Gual-Gonzalez; Mary K Lynn; Jeffrey Korte
Journal:  Public Health Rep       Date:  2022-03-10       Impact factor: 3.117

3.  Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation.

Authors:  Amanda N Pinski; Tara L Steffen; Michael Z Zulu; Sarah L George; Alexandria Dickson; Delia Tifrea; Kevin J Maroney; Neil Tedeschi; Yun Zhang; Richard H Scheuermann; Amelia K Pinto; James D Brien; Ilhem Messaoudi
Journal:  J Leukoc Biol       Date:  2021-11-03       Impact factor: 4.962

Review 4.  Rapid testing for coronavirus disease 2019 (COVID-19).

Authors:  Alexander Biby; Xiaochuan Wang; Xinliang Liu; Olivia Roberson; Allya Henry; Xiaohu Xia
Journal:  MRS Commun       Date:  2022-01-20       Impact factor: 2.935

5.  A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study.

Authors:  Parham Sendi; Rossella Baldan; Marc Thierstein; Nadja Widmer; Peter Gowland; Brigitta Gahl; Annina Elisabeth Büchi; Dominik Güntensperger; Manon Wider; Manuel Raphael Blum; Caroline Tinguely; Cédric Maillat; Elitza S Theel; Elie Berbari; Ronald Dijkman; Christoph Niederhauser
Journal:  Open Forum Infect Dis       Date:  2021-10-16       Impact factor: 3.835

6.  Missing science: A scoping study of COVID-19 epidemiological data in the United States.

Authors:  Rajiv Bhatia; Isabella Sledge; Stefan Baral
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

7.  Racial disparities in COVID-19 pandemic cases, hospitalisations, and deaths: A systematic review and meta-analysis.

Authors:  William Mude; Victor M Oguoma; Tafadzwa Nyanhanda; Lillian Mwanri; Carolyne Njue
Journal:  J Glob Health       Date:  2021-06-26       Impact factor: 4.413

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.